Applied Molecular Transpo... (AMTI)
0.26
-0.01 (-4.24%)
At close: Dec 26, 2023, 8:59 PM
-4.24% (1D)
| Bid | n/a |
| Market Cap | 11.01M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -73.14M |
| EPS (ttm) | -1.89 |
| PE Ratio (ttm) | -0.13915343915343914 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 235,210 |
| Avg. Volume (20D) | 320,195 |
| Open | 0.31 |
| Previous Close | 0.27 |
| Day's Range | 0.26 - 0.31 |
| 52-Week Range | 0.13 - 0.84 |
| Beta | 2.29 |
About AMTI
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammat...
Industry Biotechnology
Sector Healthcare
IPO Date Jun 5, 2020
Employees 13
Stock Exchange NASDAQ
Ticker Symbol AMTI
Website https://www.appliedmt.com